February 22, 2024

Registration of Indian drug products in the overseas market

Registration of Indian drug products in the overseas market

Indian Pharmaceutical Market

The Indian Pharmaceutical industry has acquired a noteworthy position in the global pharmacy sector and has been achieving significant growth in recent years.

India is among the top six global pharmaceutical producers in the world. Presently there are 10,500 manufacturing units and over 3,000 pharmacy companies in India, growing at an exceptional rate.

India has about 1,400 WHO GMP approved manufacturing units. India has been accredited with approximately 1,105 CEPs (Certificate of Suitability) more than 950 TGA approvals and 584 sites approved by the USFDA.

Structure of the Indian Pharmaceutical Sector

The Indian Pharmaceutical sector can be divided into two major segments namely, Active Pharmaceutical Ingredients (API) or bulk drugs and formulations.

The API can be branded or generic and these ingredients will be a part of formulations, which will be used to treat Acute or chronic diseases.


Export of Pharmaceuticals from India

Administrative requirements of documents and procedures for export of drugs from India. Explains the export process of pharmaceutical products, government rules to export pharmaceutical products, export documentation to export Pharmaceutical Products

A. Introduction

 A manufacturer holding valid license copy in Form-25 and Form-28 can obtain No Objection Certificate from Zonal/Sub Zonal offices of Central Drugs Standard Control Organization (CDSCO) for export purpose only for approved/unapproved new drug/banned drug in India.

B. Purpose

Requirement for the common submission format for issuance of No Objection Certificate (NOC) for export of unapproved/approved new drugs/ Banned drugs from India. This document made as per guidelines issued by Ministry of Health and Family Welfare for Export purpose and Rule 94 of Drugs and Cosmetics Act, 1940.

C. Scope

This document is applicable for the manufacturer to obtain No Objection Certificate Zonal/Sub Zonal offices of Central Drugs Standard Control Organization (CDSCO) for export purpose. 

D. Procedure

Requirement for Common submission Format for issuance of No Objection Certificate for export of unapproved / approved new drugs / Banned drugs from India

The Following documents are required to be submitted in the following manner and order for issue of the No Objection Certificate for export of drugs from India:

1. Covering Letter: The covering letter is an important part of the application and should clearly specify the intent of the application. The list of documents that are being submitted (Index with page no’s) as well as any other important and relevant information may be provided in the covering letter. The covering letter mentioning list of products to be exported clearly indicating name of the drug, dosage form, composition and strength pack size along with quantity and country to be exported duly signed and stamped by the authorized signatory, indicating the name and designation of the authorized signatory along with the name and address of the firm. Each application should be made by the manufacturer only.

2. Purchase Order: (a) Order from the foreign buyer either in the name of manufacturer or in the name of trader mentioning list of products to be exported clearly indicating name of the drug, dosage form, composition and strength pack size duly signed by the competent authority with specific destination point of the importing country. In case if the purchase order is in the name of trader, further a letter from the trader in the name of manufacturer is required to be submitted along with the application. (b) It should be signed by the competent authority/person with a valid purchase order no. and recent date not more than 6 month prior to the application made by the firm.

3. Manufacturing License: License issued by the State Licensing Authority should be enclosed along with each application for the required location to manufacture the drug for export purpose.

4. Performa Invoice: (a) A copy of Performa invoice from the importing country should accompany with application for import of unapproved Active Pharmaceutical Ingredients, used in the drug formulation. (b) A copy of Performa invoice duly signed by the competent authority should be addressed to the manufacturer mentioning the required quantity of the bulk drug. 

5. Registration Certificate: (a) For the export of drugs which are banned in India by Central government, which coming under list of drugs prohibited for manufacture and sale through gazette notifications under section 26a of drugs 8: cosmetics act 1940 by the ministry of health and family welfare. (b) A copy of registration certificate from the specific importing country along with composition and strength of the drug should accompany with the application (c) Registration certificate should be provided in the name of manufacturer.


RULES RELATED TO EXPORT DRUGS FROM INDIA

Rule 94:

Labeling and Packing of Drugs other than Homoeopathic Medicines: (1) Labels on packages or containers of drugs for export shall be adapted to meet the specific requirements of the law of the country to which the drug is to be exported but the following particulars shall appear in a conspicuous position on the innermost container in which the drug is packed and every other covering in which that container is packed: (a) Name of the drug; (b) The name, address of the manufacturer and the number of the license uncle. which the drug has been manufactured; (c) Batch or lot number; (d) Date of expiry, if any:

Rule 96:

Manner of Labeling: Subject to the other provisions of these Rules, the following particulars shall be either printed or written in indelible ink and shall appear in a conspicuous manner on the label of the innermost container of any drug and on every other covering in which the container is packed, namely: (i) The name of the drug: For this purpose, the proper name of the drug shall be printed or written in a more conspicuous manner than the trade name, if any, which shall be shown immediately after or under the proper name and shall be:

(a) For drugs included in the Schedule F or Schedule F1, the name given therein.

(b) For drugs included in the Indian Pharmacopoeia or the official pharmacopoeias and official compendia of drug standards prescribed in Rule 124, the name of synonym specified in the respective official pharmacopoeias and official compendia of drug standards followed by the letters I.P., or, as the case may be by the recognized abbreviations of the respective official pharmacopoeias and official compendia of drug standards.

(c) For drugs included in the National Formulary of India, the name or synonym specified therein followed by the letters N.F.I.

(d) for other drugs, the international non-proprietary name, if any, published by the World Health Organization or where an international non-proprietary name is not published, the name descriptive of the true nature or origin of the substance. 


GUIDELINES FOR THE EXPORT OF DRUGS ISSUED BY MINISTRY OF HEALTH AND FAMILY WELFARE

While processing such applications the following conditions shall be taken into consideration:

1. The application shall provide copy of valid export order and NOC will be issued on a case by case basis against each such order.

2. The applicant shall identify the premises where the drug will be manufactured for export.

3. The applicant should mention whether the batch to be exported has undergone Quality control testing or shall be tested at the destined site.

4. The applicant shall ensure that the drug(s) manufactured on the basis of NOC given as above its exported and that no part of it is diverted for domestic sale in India.

5. The applicant shall make available for inspection of the appropriate authorities, on completion of the export orders, information regarding each consignment dispatched, remaining stock of drug and related raw materials and intermediates in hand.

6. The applicant shall ensure physical destruction of all un exported quantity of drugs. This should be included as a condition of manufacturing license issued to the applicant by the State licensing authority.

7. The applicant shall ensure that the drug for which NOC has been given shall cease to be manufactured or exported if the drug is prohibited in future in the country or in the importing country.


Final Year B Pharm Notes, Syllabus, Books, PDF Subjectwise/Topicwise

Final Year B Pharm Sem VIIBP701T Instrumental Methods of Analysis Theory
BP702T Industrial Pharmacy TheoryBP703T Pharmacy Practice Theory
BP704T Novel Drug Delivery System TheoryBP705 P Instrumental Methods of Analysis Practical
Final Year B Pharm Sem VIIBP801T Biostatistics and Research Methodology Theory
BP802T Social and Preventive Pharmacy TheoryBP803ET Pharmaceutical Marketing Theory
BP804ET Pharmaceutical Regulatory Science TheoryBP805ET Pharmacovigilance Theory
BP806ET Quality Control and Standardization of Herbals TheoryBP807ET Computer-Aided Drug Design Theory
BP808ET Cell and Molecular Biology TheoryBP809ET Cosmetic Science Theory
BP810ET Experimental Pharmacology TheoryBP811ET Advanced Instrumentation Techniques Theory
BP812ET Dietary supplements and NutraceuticalsPharmaceutical Product Development

Suggested readings:


Recommended readings:

IPC Nagpur